BBIO Stock Analysis: Buy, Sell, or Hold?
BBIO - BridgeBio Pharma, Inc. Common Stock
$74.84
-0.57 (-0.76%)
▼
5d:
-2.3%
30d:
-9.61%
90d:
+10.69%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When BBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BBIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BBIO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: BBIO is currently trading at $74.84, which is considered oversold relative to its 30-day fair value range of $77.96 to $83.86. From a valuation perspective, the stock is trading at a premium (Forward PE: 2721.4) compared to its historical average (207.4). At these levels, the market is pricing in 135.8% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is currently testing key support at $74.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BBIO scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $109.10 (+45.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BBIO is in a strong uptrend. The price is currently testing key support at $74.11. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: BBIO scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $109.10 (+45.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$77.96 -
$83.86
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding BBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.8% below Wall St target ($109.10)
- BEARISH: Market expects 135.8% growth - appears too optimistic based on history
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$77.96 -
$83.86
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$74.11
Resistance Level
$82.50
Current Trend
Strong Uptrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2721.45
Wall Street Target
$109.10
(+45.8%)
Revenue Growth (YoY)
120.4%
Profit Margin
-97.0%
Valuation Premium vs History
+135.8% premium
PE vs Historical
2721.5 vs 207.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+135.8%
(market-implied from PE analysis)
1-Year Target
$112.26
(+50%)
2-Year Target
$168.39
(+125%)
3-Year Target
$252.59
(+238%)
3-Yr Target (if PE normalizes)
(PE: 2721→207)
PE COMPRESSION
$19.25
(-74%)
Significant PE compression expected
Share & Embed Analysis
Last updated: September 05, 2026 8:12 AM ET
Data refreshes hourly during market hours. Next update: 9:12 AM
Data refreshes hourly during market hours. Next update: 9:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBIO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
2
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Neil Kumar
SELL
40000 shares
2026-04-09
Gilbert Ray Cisneros, Jr.
BUY
2026-03-19
Gilbert Ray Cisneros, Jr.
BUY
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 48 HOLD |
Advanced BBIO Option Strategies
Professional options setups generated by AI based on today's BBIO price and gamma walls.
